Skip to main content
. 2016 Mar 22;127(22):2742–2750. doi: 10.1182/blood-2016-01-690230

Table 3.

Treatment response based on the emergence time of ACAs

Time Group 1 Group 2
Trisomy 8 −Y Extra Ph i(17)(q10) −7/del(7q) 3q26
At CML diagnosis
 CCyR 4/4 (100%) 10/14 (71%) 4/4 (100%) 0/2 (0%) 0/1 (0%) 0/2 (0%)
 MMR 3/4 (75%) 9/14 (64%) 4/4 (100%) 0/2 (0%) 0/1 (0%) 0/17 (0%)
During the course
 CCyR 8/18 (44%) 7/12 (58%) 8/15 (53%) 2/13 (15%) 1/3 (33%) 0/2 (0%)
 MMR 8/18 (44%) 7/12 (58%) 6/15 (40%) 1/13 (8%) 0/3 (0%) 0/17 (0%)